Li, M., Wang, S., Xiao, H., Hu, R., & Xie, Y. (2026). The FAP+ CAF subset in bladder cancer: A key driver of cancer cell stemness and a promising target for FAPI therapy. Clinical & Translational Discovery, 6(4), 1. https://doi.org/10.1002/ctd2.70179
Chicago Style (17th ed.) CitationLi, Meiqian, Shikun Wang, Hua Xiao, Rong Hu, and Yueyun Xie. "The FAP+ CAF Subset in Bladder Cancer: A Key Driver of Cancer Cell Stemness and a Promising Target for FAPI Therapy." Clinical & Translational Discovery 6, no. 4 (2026): 1. https://doi.org/10.1002/ctd2.70179.
MLA (9th ed.) CitationLi, Meiqian, et al. "The FAP+ CAF Subset in Bladder Cancer: A Key Driver of Cancer Cell Stemness and a Promising Target for FAPI Therapy." Clinical & Translational Discovery, vol. 6, no. 4, 2026, p. 1, https://doi.org/10.1002/ctd2.70179.